Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TIMBER PHARMACEUTICALS, INC.

(TMBR)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

TIMBER PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)

04/16/2021 | 04:33pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.



On April 13, 2021, Timber Pharmaceuticals, Inc. (the "Company") received notice from Michael Derby, Executive Chairman of the Company's Board of Directors (the "Board"), that he will step down and resign as an officer and director of the Company effective April 16, 2021. Mr. Derby's resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. There are no disagreements between the Company and Mr. Derby regarding Mr. Derby's resignation. Mr. Derby indicated that he felt he had achieved his goal of forming the Company and overseeing its initial year of operations after becoming a public company. He intends to pursue other business interests at this time. He will remain as the managing partner of TardiMed Sciences LLC.

© Edgar Online, source Glimpses

All news about TIMBER PHARMACEUTICALS, INC.
05/05TIMBER PHARMACEUTICALSá : Files for Up to $100 Million Mixed Shelf
MT
04/28TIMBER PHARMACEUTICALSá : Company is evaluating a topical pharmaceutical composi..
PU
04/28TIMBER PHARMACEUTICALS, INC.á : Other Events, Financial Statements and Exhibits ..
AQ
04/28Timber Pharmaceuticals Receives Decision to Grant Japanese Patent for Lead As..
GL
04/27TIMBER PHARMACEUTICALS : Funding Only Into Q3 2021, But Some Hidden Value Remain..
PU
04/26TIMBER PHARMACEUTICALSá : RIOT, MARA, OCGN and MVIS among notable premarket gain..
PU
04/23TIMBER PHARMACEUTICALSá : Names CEO John Koconis Chairman of the Board
MT
04/23TIMBER PHARMACEUTICALS, INC.á : Other Events, Financial Statements and Exhibits ..
AQ
04/23Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of t..
GL
04/22NETHERTON SYNDROME PIPELINE : Emerging Therapies and Key pharma players involved..
AQ
More news
Financials (USD)
Sales 2020 0,45 M - -
Net income 2020 -15,1 M - -
Net cash 2020 9,51 M - -
P/E ratio 2020 -0,76x
Yield 2020 -
Capitalization 40,3 M 40,3 M -
EV / Sales 2019 -
EV / Sales 2020 -1,26x
Nbr of Employees 6
Free-Float 17,5%
Chart TIMBER PHARMACEUTICALS, INC.
Duration : Period :
Timber Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TIMBER PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
NameTitle
John Koconis Chairman & Chief Executive Officer
Joseph Lucchese Chief Financial Officer & Executive Vice President
Alan Mendelsohn Chief Medical Officer & Executive Vice President
Zachary Rome COO, Secretary, Director & Executive VP
Edward J. Sitar Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TIMBER PHARMACEUTICALS, INC.48.05%40
MODERNA, INC.51.77%63 662
LONZA GROUP AG-0.91%46 541
IQVIA HOLDINGS INC.29.20%44 368
CELLTRION, INC.-25.77%33 740
SEAGEN INC.-22.39%24 668